# About This Desk — Peptide Research Alliance

> About Peptide Research Alliance: an independent literature digest covering research peptide fundamentals — editorial method, citation standards, and what this desk is and is not.

What Peptide Research Alliance is, how it selects and cites literature, and what it explicitly does not do.

## What this desk is

Peptide Research Alliance is an independent editorial desk organized around the **research-fundamentals frame**: the five most-studied and most-discussed research compounds across the major categories that come up in research-peptide conversations — tissue repair, the growth-hormone axis, metabolic pharmacology, skin biology, and cellular-energy longevity.

The five compounds covered here — BPC-157, Retatrutide, Ipamorelin, GHK-Cu, and NAD+ — are not curated to imply equivalence. They span different molecular classes (peptides, a coenzyme), different regulatory categories (research chemicals, an investigational drug, a cosmetic ingredient, a dietary supplement), and very different evidence maturities (rodent-only to Phase 3 clinical trials). What they share is that each one is a reference point in its research category, and that accurate characterization of each one is directly useful to researchers, science journalists, and informed readers trying to understand what the published evidence actually shows.

This is a digest, not a clinic and not a vendor. It publishes no prices, no purchase pathways, and no human doses.

## Editorial method and citation standards

All claims on this desk are sourced to peer-reviewed literature: PubMed-indexed journals, preprints with established track records, and registered clinical trial publications. Citations are numbered by their position in the site's [references list](/references), and every in-text citation number links directly to the relevant source entry.

The editorial standard is: **study-attributed claims only**. When this desk says that a compound produced an effect, it specifies the species, the model, the endpoint, and the publication. It does not convert animal findings into human benefit claims. Where a trial failed its primary endpoint, that fact is reported clearly. Where evidence comes predominantly from a single research group, that provenance is noted. Where claims in popular discussion exceed what the published evidence supports, that gap is stated plainly.

Community-reported effects — what people in research-use contexts describe experiencing — are included on compound pages as a separate, clearly labeled section: **anecdotal, not clinical evidence**. They are informative about how these compounds are perceived in research communities and about what is most frequently observed in uncontrolled use, but they are not treated as evidence of efficacy or safety.

References are audited for accessibility: wherever a DOI or PMID is available, it is provided. Paywalled sources are noted as such; open-access versions are linked where available.

## Independence and disclaimer

Peptide Research Alliance has no affiliation with any manufacturer, supplier, compounding pharmacy, clinic, or any commercial entity selling the compounds described here. It receives no revenue from product sales, referrals, or affiliate links. Editorial decisions are made solely on the basis of scientific accuracy and relevance to the research-fundamentals frame.

This desk does not provide medical advice. It does not diagnose, treat, prevent, or cure any disease or condition. The compounds described here are not approved for human therapeutic use (with the narrow exceptions noted on the relevant compound pages). Individuals with medical questions should consult a licensed healthcare professional. The content here is for informational and research-orientation purposes only.

---

An independent literature digest of peer-reviewed research — definitional, cited, and free of products, prescriptions, and dosing recommendations.